Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial.

Sood N, Al Badarin F, Parker M, Pullatt R, Jacobson AF, Bateman TM, Heller GV.

J Nucl Cardiol. 2013 Oct;20(5):813-20. doi: 10.1007/s12350-013-9750-y. Epub 2013 Jul 18.

PMID:
23864400
2.

Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.

Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J; ADMIRE-HF Investigators.

J Am Coll Cardiol. 2010 May 18;55(20):2212-21. doi: 10.1016/j.jacc.2010.01.014. Epub 2010 Feb 25.

3.

Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.

Marshall A, Cheetham A, George RS, Mason M, Kelion AD.

Heart. 2012 Sep;98(18):1359-65. doi: 10.1136/heartjnl-2012-302321.

PMID:
22904144
4.

Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.

Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI, Shimamoto K.

J Nucl Med. 2001 Dec;42(12):1757-67.

5.

The relationship of left ventricular mechanical dyssynchrony and cardiac sympathetic denervation to potential sudden cardiac death events in systolic heart failure.

Hage FG, Aggarwal H, Patel K, Chen J, Jacobson AF, Heo J, Ahmed A, Iskandrian AE.

J Nucl Cardiol. 2014 Feb;21(1):78-85. doi: 10.1007/s12350-013-9807-y. Epub 2013 Oct 30.

PMID:
24170623
6.

The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac 123I-mIBG scintigraphy.

Al Badarin FJ, Wimmer AP, Kennedy KF, Jacobson AF, Bateman TM.

J Nucl Cardiol. 2014 Aug;21(4):756-62; quiz 753-55, 763-5.

PMID:
25015681
7.

Myocardial perfusion, function, and dyssynchrony in patients with heart failure: baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial.

Atchley AE, Kitzman DW, Whellan DJ, Iskandrian AE, Ellis SJ, Pagnanelli RA, Kao A, Abdul-Nour K, O'Connor CM, Ewald G, Kraus WE, Borges-Neto S; HF-ACTION Investigators.

Am Heart J. 2009 Oct;158(4 Suppl):S53-63. doi: 10.1016/j.ahj.2009.07.009.

8.

Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.

Shah AM, Bourgoun M, Narula J, Jacobson AF, Solomon SD.

JACC Cardiovasc Imaging. 2012 Nov;5(11):1139-46. doi: 10.1016/j.jcmg.2012.02.019.

9.

Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy.

Wichter T, Hindricks G, Lerch H, Bartenstein P, Borggrefe M, Schober O, Breithardt G.

Circulation. 1994 Feb;89(2):667-83.

PMID:
8313555
10.

Risk stratification of patients with prior myocardial infarction and advanced left ventricular dysfunction by gated myocardial perfusion SPECT imaging.

Morishima I, Sone T, Tsuboi H, Mukawa H, Uesugi M, Morikawa S, Takagi K, Niwa T, Morita Y, Murakami R, Numaguchi Y, Murohara T, Okumura K.

J Nucl Cardiol. 2008 Sep-Oct;15(5):631-7. doi: 10.1016/j.nuclcard.2008.03.009. Epub 2008 Jun 12.

PMID:
18761265
11.

I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.

Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, Unlu M, Estorch M, Banerjee G, Jacobson AF.

Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):535-46. Epub 2007 Nov 28.

PMID:
18043919
12.

Stress variables add differential diagnostic information between ischemic and nonischemic cardiomyopathy over myocardial perfusion SPECT imaging.

Romero-Farina G, Aguadé-Bruix S, Candell-Riera J, Castell-Conesa J, Fernández-Sálguero R, García-Dorado D.

Nucl Med Commun. 2013 Feb;34(2):117-23. doi: 10.1097/MNM.0b013e32835c08a4.

PMID:
23211995
13.

123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study.

Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parízek P, Agostini D, Knuuti J, Flotats A, Arrighi J, Muxi A, Alibelli MJ, Banerjee G, Jacobson AF.

Circ Cardiovasc Imaging. 2008 Sep;1(2):131-40. doi: 10.1161/CIRCIMAGING.108.782433. Epub 2008 Jul 30. Erratum in: Circ Cardiovasc Imaging. 2009 Mar;2(2):e14.

14.

Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy.

Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, Saba SF, Gorcsan J 3rd.

Eur Heart J. 2011 Jan;32(1):93-103. doi: 10.1093/eurheartj/ehq389. Epub 2010 Oct 22.

15.

Prognostic value of left ventricular mechanical dyssynchrony by phase analysis in patients with non-ischemic cardiomyopathy with ejection fraction 35-50% and QRS < 150 ms.

Goldberg AS, Alraies MC, Cerqueira MD, Jaber WA, Aljaroudi WA.

J Nucl Cardiol. 2014 Feb;21(1):57-66. doi: 10.1007/s12350-013-9787-y. Epub 2013 Oct 4.

PMID:
24092272
16.

Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.

Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ.

J Am Coll Cardiol. 2010 Jun 15;55(24):2769-77. doi: 10.1016/j.jacc.2009.12.066.

17.
18.

123I-MIBG myocardial scintigraphy in diabetic patients: relationship with 201Tl uptake and cardiac autonomic function.

Nagamachi S, Jinnouchi S, Kurose T, Ohnishi T, Flores LG 2nd, Nakahara H, Futami S, Tamura S, Matsukura S.

Ann Nucl Med. 1998 Dec;12(6):323-31.

PMID:
9972369
19.

Relationship of technetium-99m tetrofosmin-gated rest single-photon emission computed tomography myocardial perfusion imaging to death and hospitalization in heart failure patients: results from the nuclear ancillary study of the HF-ACTION trial.

Atchley AE, Iskandrian AE, Bensimhon D, Ellis SJ, Kitzman DW, Shaw LK, Pagnanelli RA, Whellan DJ, Gardin JM, Kao A, Abdul-Nour K, Ewald G, Walsh MN, Kraus WE, O'Connor CM, Borges-Neto S; HF-ACTION Trial Nuclear Ancillary Study Investigators.

Am Heart J. 2011 Jun;161(6):1038-45. doi: 10.1016/j.ahj.2011.02.007. Epub 2011 Apr 6.

20.

Impact of appropriate use on the prognostic value of single-photon emission computed tomography myocardial perfusion imaging.

Doukky R, Hayes K, Frogge N, Balakrishnan G, Dontaraju VS, Rangel MO, Golzar Y, Garcia-Sayan E, Hendel RC.

Circulation. 2013 Oct 8;128(15):1634-43. doi: 10.1161/CIRCULATIONAHA.113.002744. Epub 2013 Sep 10.

Items per page

Supplemental Content

Write to the Help Desk